Illinois General Assembly - Full Text of SB1413
Illinois General Assembly

Previous General Assemblies

Full Text of SB1413  103rd General Assembly

SB1413 103RD GENERAL ASSEMBLY

  
  

 


 
103RD GENERAL ASSEMBLY
State of Illinois
2023 and 2024
SB1413

 

Introduced 2/6/2023, by Sen. Sue Rezin

 

SYNOPSIS AS INTRODUCED:
 
New Act

    Creates the Sale of Pharmaceuticals on Social Media Act. Provides that, notwithstanding any other provision of law, no individual shall sell or advertise the sale of a pharmaceutical on social media unless the individual has completed a verification process with specified requirements.


LRB103 28324 CPF 54703 b

 

 

A BILL FOR

 

SB1413LRB103 28324 CPF 54703 b

1    AN ACT concerning regulation.
 
2    Be it enacted by the People of the State of Illinois,
3represented in the General Assembly:
 
4    Section 1. Short title. This Act may be cited as the Sale
5of Pharmaceuticals on Social Media Act.
 
6    Section 5. Definition. In this Act, "social media" has the
7same meaning as defined in Section 6-5 of the Liquor Control
8Act of 1934.
 
9    Section 10. Sale of pharmaceuticals on social media;
10verification process. Notwithstanding any other provision of
11law, no individual shall sell or advertise the sale of a
12pharmaceutical on social media unless the individual has
13completed the following verification process:
14        (1) the individual shall submit an image of both the
15    front and back of the individual's state-issued
16    identification card to the social media platform upon or
17    through which the pharmaceutical is to be sold or
18    advertised;
19        (2) a disclaimer must be included in any advertisement
20    for the pharmaceutical on the social media platform that
21    clearly discloses the name of the individual selling the
22    pharmaceutical;

 

 

SB1413- 2 -LRB103 28324 CPF 54703 b

1        (3) the individual must be identified on the social
2    media page upon which the pharmaceutical is being sold or
3    advertised; and
4        (4) the individual must display a disclaimer on the
5    individual's main page on the social media platform
6    stating that the owner or operator sells or advertises the
7    pharmaceutical on that social media platform.